1Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst, 1995, 87: 796-802.
2Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic cvidence showing that human papillomavirus infection cruses most cervical intraepithelial neoplasia. J Natl Cancer Inst,1993,85: 958-964.
3Walboomers JM, Jaclbs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999,189:12-19.
4Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohorts study. Lancet, 2001, 357:1831-1836.
5Liaw KL, Glass AG, Manos MM, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst, 1999, 91: 954-960.
6Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet, 1999, 354: 20-25.
8Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol, 1986, 67:664-669.
9Peyton CL, Schiffman M,Lrincz AT, et al. Comparison of PCR and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol,1998,36: 3248-3254.Peyton CL, Schiffman M,Lrincz AT, et al. Comparison of PCR and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol, 1998, 36: 3248-3254.
3Clavel C, Masure M, Putaud I, et al. Hybrid Capture-Ⅱ, a new sensitive test for human papiUomavirus detection.Comparison with Hybrid Capture I and PCR results in cervical lesions. J Clin Pathol, 1998, 51(9):737-740.
4Sun XW, Ferenczy A, Johnson D, et al. Evaluation of the Hybrid Capture human papiUomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol, 1995, 173:1432-1437.
5Levert M, Clavel C, Graesslin O, et al. Human papillomavirus typing in routine cervical smears: results from a series of 3778 patients. Gynecol Obstet Fertil, 2000, 28(10):722-728.
6Solomon D, Schiffman M, Tarone R, et ol. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Nail Cancer Inst, 2001, 93(4):293-299.
7Schneider A, Hoyer H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or eolposeopy.Int J Cancer, 2000, 89(6):529-534.
8Clavel C, Masure M, Bory JP, et al. Hybrid Capture Ⅱ-based human papiUomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer, 1999, 80(9):1306-1311.
9Clavel C, Masure M, Levert M, et al. H,man papillomavirusdetection by the hybrid capture I1 assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol, 2000, 9(3):145-150.
10Bosch FX, Manos MM, Munos N, et al. Prevalence of human papillomavirus in cervical cancer:a worldwide perspective. J Natl Cancer Inst, 1995, 87:796-802.
